Handelsbanken Fonder’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $851K | Sell |
32,100
-3,700
| -10% | -$98.1K | ﹤0.01% | 1034 |
|
|
2025
Q1 | $865K | Sell |
35,800
-147,600
| -80% | -$3.57M | ﹤0.01% | 996 |
|
|
2024
Q4 | $7.38M | Buy |
183,400
+3,400
| +2% | +$137K | 0.03% | 394 |
|
|
2024
Q3 | $11.4M | Buy |
180,000
+158,100
| +722% | +$10M | 0.05% | 329 |
|
|
2024
Q2 | $1.16M | Sell |
21,900
-6,400
| -23% | -$339K | 0.01% | 775 |
|
|
2024
Q1 | $2.32M | Buy |
28,300
+5,600
| +25% | +$459K | 0.01% | 566 |
|
|
2023
Q4 | $422K | Buy |
22,700
+7,300
| +47% | +$136K | ﹤0.01% | 1227 |
|
|
2023
Q3 | $170K | Hold |
15,400
| – | – | ﹤0.01% | 1502 |
|
|
2023
Q2 | $250K | Buy |
+15,400
| New | +$250K | ﹤0.01% | 1418 |
|